Catherine H Van Poznak (Catherine Van Poznak)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 13

Top Topics

Clinical Practice

Epidermal Growth Factor Receptor

Metastatic Breast Cancer

Top Venues

Breast cancer research and treatment

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

The Journal of clinical endocrinology and metabolism

NPJ breast cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Paolo Tarantino, Nabihah Tayob, Guillermo Villacampa, Chau Dang, Denise A Yardley, Steven Jay Isakoff, Vicente Valero, Meredith Faggen, Therese Marie Mulvey, Ron Bose, Douglas Weckstein, Antonio C Wolff, Katherine E Reeder-Hayes, Hope S Rugo, Bhuvaneswari Ramaswamy, Dan Zuckerman, Lowell Hart, Vijayakrishna K Gadi, Michael Constantine, Kit Cheng, Audrey Merrill Garrett, P Kelly Marcom, Kathy S Albain, Patricia DeFusco, Nadine M Tung, Blair Ardman, Rita Nanda, Rachel C Jankowitz, Mothaffar F Rimawi, Vandana G Abramson, Paula R Pohlmann, Catherine H Van Poznak, Andres Forero-Torres, Minetta C Liu, Kathryn J Ruddy, Adrienne G Waks, Michelle DeMeo, Harold J Burstein, Ann H Partridge, Patrizia Dell'Orto, Leila Russo, Emma Krause, Daniel J Newhouse, Busem Binboğa Kurt, Elizabeth A Mittendorf, Bryan Paul Schneider, Adrienne G Waks, Eric P Winer, Ian E Krop, Sara M Tolaney, null null, null null
Adjuvant Trastuzumab Emtansine Versus Paclitaxel Plus Trastuzumab for Stage I Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: 5-Year Results and Correlative Analyses From ATEMPT. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Hope S Rugo, Catherine H Van Poznak, Patrick Neven, Iwona Danielewicz, Soo-Chin Lee, Mario Campone, Jeannie Y K Chik, Estela Vega Alonso, Bjørn Naume, Etienne G C Brain, Jonathan M Siegel, Rui Li, Deise Uema, Volker J Wagner, Robert E Coleman
Radium-223 in women with hormone receptor-positive bone-metastatic breast cancer receiving endocrine therapy: pooled analysis of two international, phase 2, randomized, double-blind, placebo-controlled trials. Breast cancer research and treatment 204 (2) (2023)
Hope S Rugo, Catherine H Van Poznak, Patrick Neven, Iwona Danielewicz, Soo-Chin Lee, Mario Campone, Jeannie Y K Chik, Estela Vega Alonso, Bjørn Naume, Etienne G C Brain, Jonathan M Siegel, Rui Li, Deise Uema, Volker J Wagner, Robert E Coleman
Radium-223 in women with hormone receptor-positive bone-metastatic breast cancer receiving endocrine therapy: pooled analysis of two international, phase 2, randomized, double-blind, placebo-controlled trials. Breast cancer research and treatment 204 (2) (2023)
Carolien P Schröder, Elise van Leeuwen-Stok, Fatima Cardoso, Barbro Linderholm, Coralie Poncet, Antonio C Wolff, Vesna Bjelic-Radisic, Gustavo Werutsky, Miguel H Abreu, Ivana Bozovic-Spasojevic, Irma den Hoed, Aafke H Honkoop, Maartje Los, Jose P Leone, Nicola S Russell, Tineke J Smilde, Annette W G van der Velden, Catherine H Van Poznak, Marije M Vleugel, Rachel L Yung, Corneel Coens, Sharon H Giordano, Kathryn J Ruddy
Quality of Life in Male Breast Cancer: Prospective Study of the International Male Breast Cancer Program (EORTC10085/TBCRC029/BIG2-07/NABCG). The oncologist (2023)
Ghada El-Hajj Fuleihan, Gregory A Clines, Mimi I Hu, Claudio Marcocci, Mohammad Hassan Murad, Thomas Piggott, Catherine H Van Poznak, Joy Y Wu, Matthew T Drake
Treatment of Hypercalcemia of Malignancy in Adults: An Endocrine Society Clinical Practice Guideline. The Journal of clinical endocrinology and metabolism 108 (3) (2023)
Hope S Rugo, Catherine H Van Poznak, Patrick Neven, Iwona Danielewicz, Soo-Chin Lee, Mario Campone, Jeannie Y K Chik, Estela Vega Alonso, Bjørn Naume, Etienne G C Brain, Jonathan M Siegel, Rui Li, Deise Uema, Volker J Wagner, Robert E Coleman
Radium-223 in women with hormone receptor-positive bone-metastatic breast cancer receiving endocrine therapy: pooled analysis of two international, phase 2, randomized, double-blind, placebo-controlled trials. Breast cancer research and treatment 204 (2) (2023)
Hope S Rugo, Catherine H Van Poznak, Patrick Neven, Iwona Danielewicz, Soo-Chin Lee, Mario Campone, Jeannie Y K Chik, Estela Vega Alonso, Bjørn Naume, Etienne G C Brain, Jonathan M Siegel, Rui Li, Deise Uema, Volker J Wagner, Robert E Coleman
Radium-223 in women with hormone receptor-positive bone-metastatic breast cancer receiving endocrine therapy: pooled analysis of two international, phase 2, randomized, double-blind, placebo-controlled trials. Breast cancer research and treatment 204 (2) (2023)
Hope S Rugo, Catherine H Van Poznak, Patrick Neven, Iwona Danielewicz, Soo-Chin Lee, Mario Campone, Jeannie Y K Chik, Estela Vega Alonso, Bjørn Naume, Etienne G C Brain, Jonathan M Siegel, Rui Li, Deise Uema, Volker J Wagner, Robert E Coleman
Radium-223 in women with hormone receptor-positive bone-metastatic breast cancer receiving endocrine therapy: pooled analysis of two international, phase 2, randomized, double-blind, placebo-controlled trials. Breast cancer research and treatment (2023)
Andrea Eisen, Mark R Somerfield, Melissa K Accordino, Phillip S Blanchette, Mark J Clemons, Sukhbinder Dhesy-Thind, Melissa S Dillmon, Stella D'Oronzo, Glenn G Fletcher, Elizabeth S Frank, Sigrun Hallmeyer, Issam Makhoul, Beverly Moy, Alia Thawer, Joy Y Wu, Catherine H Van Poznak
Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: ASCO-OH (CCO) Guideline Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (7) (2022)
Romualdo Barroso-Sousa, Paolo Tarantino, Nabihah Tayob, Chau T Dang, Denise A Yardley, Steven J Isakoff, Vicente Valero, Meredith Faggen, Therese Mulvey, Ron Bose, Jiani Hu, Douglas Weckstein, Antonio C Wolff, Katherine Reeder-Hayes, Hope S Rugo, Bhuvaneswari Ramaswamy, Dan Zuckerman, Lowell Hart, Vijayakrishna K Gadi, Michael Constantine, Kit Cheng, Frederick Briccetti, Bryan Schneider, Audrey Merrill Garrett, P Kelly Marcom, Kathy Albain, Patricia DeFusco, Nadine Tung, Blair Ardman, Rita Nanda, Rachel C Jankowitz, Mothaffar F Rimawi, Vandana Abramson, Paula R Pohlmann, Catherine H Van Poznak, Andres Forero-Torres, Minetta C Liu, Kathryn J Ruddy, Yue Zheng, Shoshana M Rosenberg, Richard D Gelber, Lorenzo Trippa, William Barry, Michelle DeMeo, Harold Burstein, Ann H Partridge, Eric P Winer, Ian E Krop, Sara M Tolaney
Cardiac outcomes of subjects on adjuvant trastuzumab emtansine vs paclitaxel in combination with trastuzumab for stage I HER2-positive breast cancer (ATEMPT) study (TBCRC033): a randomized controlled trial. NPJ breast cancer 8 (1) (2022)
Ghada El-Hajj Fuleihan, Gregory A Clines, Mimi I Hu, Claudio Marcocci, Mohammad Hassan Murad, Thomas Piggott, Catherine H Van Poznak, Joy Y Wu, Matthew T Drake
Treatment of Hypercalcemia of Malignancy in Adults: An Endocrine Society Clinical Practice Guideline. The Journal of clinical endocrinology and metabolism (2022)
Sara M Tolaney, Nabihah Tayob, Chau Dang, Denise A Yardley, Steven Jay Isakoff, Vicente Valero, Meredith Faggen, Therese Marie Mulvey, Ron Bose, Jiani Hu, Douglas Weckstein, Antonio C Wolff, Katherine E Reeder-Hayes, Hope S Rugo, Bhuvaneswari Ramaswamy, Dan Zuckerman, Lowell Hart, Vijayakrishna K Gadi, Michael Constantine, Kit Cheng, Frederick Briccetti, Bryan Paul Schneider, Audrey Merrill Garrett, P Kelly Marcom, Kathy S Albain, Patricia DeFusco, Nadine M Tung, Blair Ardman, Rita Nanda, Rachel C Jankowitz, Mothaffar F Rimawi, Vandana G Abramson, Paula R Pohlmann, Catherine H Van Poznak, Andres Forero-Torres, Minetta C Liu, Kathryn J Ruddy, Yue Zheng, Shoshana M Rosenberg, Richard D Gelber, Lorenzo Trippa, William Barry, Michelle DeMeo, Harold Burstein, Ann H Partridge, Eric P Winer, Ian E Krop
Adjuvant Trastuzumab Emtansine Versus Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT): A Randomized Clinical Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (21) (2021)
Virginia Falvello, Catherine H Van Poznak
Updates in Management of Bone Metastatic Disease in Primary Solid Tumors with Systemic Therapies. Current osteoporosis reports 19 (4) (2021)